GH Research (GHRS) Assets (2021 - 2025)
GH Research (GHRS) recorded quarterly Assets of $288.2 million in Q4 2025, down 4.57% quarter-over-quarter from $302.0 million in Q3 2025, and up 53.09% on a YoY basis from $188.3 million in Q4 2024.
GH Research (GHRS) Assets (2021 - 2025) Analysis & Trends
GH Research's Assets history runs 5 years deep, the most recent figure standing at $288.2 million for Q4 2025.
- In Q4 2025, Assets rose 53.09% year-over-year to $288.2 million; the TTM figure through Dec 2025 stood at $288.2 million (up 53.09% YoY), while the FY2025 annual figure was $288.2 million, up 53.09% from the prior year.
- Assets was $288.2 million for Q4 2025 at GH Research, down from $302.0 million in the prior quarter.
- In the past five years, Assets ranged from a high of $320.5 million in Q1 2025 to a low of $188.3 million in Q4 2024.
- Historically, Assets has averaged $256.3 million across 5 years, with a median of $257.2 million in 2022.
- The sharpest annual moves came in 2024 and 2025: Assets fell 16.8% in 2024, then soared 53.09% in 2025.
- A 5-year view of Assets shows it stood at $288.1 million in 2021, then slipped by 11.71% to $254.4 million in 2022, then declined by 11.03% to $226.3 million in 2023, then declined by 16.8% to $188.3 million in 2024, then jumped by 53.09% to $288.2 million in 2025.
- The last three Assets figures came in at $288.2 million (Q4 2025), $302.0 million (Q3 2025), and $313.4 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - | 37.37 Mn |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - | 811.27 Mn |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - | 14.93 Mn |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn | 1.73 Bn |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - | 33.89 Mn |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - | 23.64 Mn |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - | 12.81 Mn |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn | 26.48 Bn |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - | 640.56 Mn |
| 10 | GH Research | 9.73 Bn | 9.63 Bn | - | 288.23 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 288.23 Mn |
| Sep 30, 2025 | 302.02 Mn |
| Jun 30, 2025 | 313.43 Mn |
| Mar 31, 2025 | 320.45 Mn |
| Dec 31, 2024 | 188.27 Mn |
| Sep 30, 2024 | 199.61 Mn |
| Jun 30, 2024 | 206.98 Mn |
| Mar 31, 2024 | 217.58 Mn |
| Dec 31, 2023 | 226.30 Mn |
| Sep 30, 2023 | 232.57 Mn |
| Jun 30, 2023 | 240.27 Mn |
| Mar 31, 2023 | 249.26 Mn |
| Dec 31, 2022 | 254.36 Mn |
| Sep 30, 2022 | 260.12 Mn |
| Jun 30, 2022 | 266.32 Mn |
| Mar 31, 2022 | 273.54 Mn |
| Dec 31, 2021 | 288.11 Mn |
| Sep 30, 2021 | 285.63 Mn |